🇺🇸 FDA
Pipeline program

BULEVIRTIDE, BJT-778

BJT-778-303

Phase 3 small_molecule active

Quick answer

BULEVIRTIDE, BJT-778 for Chronic Hepatitis D Infection is a Phase 3 program (small_molecule) at Blue Earth Diagnostics Ireland Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Blue Earth Diagnostics Ireland Ltd
Indication
Chronic Hepatitis D Infection
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials